Do Big Money Love CVS Caremark Corp (NYSE:CVS), Sentiment at 0.72

May 16, 2018 - By Vernon Prom

CVS Health Corporation (NYSE:CVS) Corporate Logo

Positions for CVS Caremark Corp (NYSE:CVS)

“Big money sentiment for CVS Caremark Corp (NYSE:CVS) in Q4 2017 decreased to 0.72, according to Securities and Exchange Commission filings. So its down -0.16, from 2017Q3’s 0.88. 514 institutional investors started new and increased positions, while 715 cut down and sold stock positions in CVS Caremark Corp so the sentiment fall. Funds own 815.59 million shares, up from 801.45 million shares in 2017Q3. Funds holding CVS Caremark Corp in top 10 decreased from 59 to 30 for a decrease of 29. In total 115 funds closed positions, 600 reduced and 380 increased. Also 134 funds bought new CVS Caremark Corp stakes.

Most CVS Caremark Corp Investors

Veritas Investment Management Llp owns 718,928 shares in CVS Caremark Corp as of Q4 2017. CVS Caremark Corp’s shareholder Cortland Associates Inc Mo owns 513,230 shares as of Q4 2017. St. James Investment Company Llc reported 786,377 shares. The United Kingdom-based fund Veritas Asset Management Llp have invested about 6.58% of the investment professional’s stock portfolio in CVS Caremark Corp. The New York-based fund Senzar Asset Management Llc holds 315,500 shares or 5.84% of their stock exposure.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services.The firm is valued at $67.22 billion. It operates through Pharmacy Services and Retail/LTC divisions.10.26 is the P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

CVS reached $66.12 during the last trading session after $0.28 change.CVS Health Corporation has volume of 3.94M shares. Since May 16, 2017 CVS has declined 22.81% and is downtrending. CVS underperformed by 34.36% the S&P 500.

CVS Health Corporation (NYSE:CVS)’s earnings report is anticipated on August, 14., according to RTT. Analysts forecast 21.05 % diference or $1.61 from the $1.33 EPS from 2017. This could reach $1.64 billion profit for CVS assuming the current $1.61 EPS will become reality. After $1.48 EPS report last quarter, Wall Street now predicts 8.78 % EPS growth of CVS Health Corporation.

Reliance Of Delaware reported 0.47% stake. Tocqueville Asset Mgmt Ltd Partnership, New York-based fund reported 11,231 shs. Beacon Advisors holds 1.25% or 1,616 shs in its capital. Colony Grp Limited Liability has 0.78% invested in CVS Health Corporation (NYSE:CVS) for 171,279 shs. Dekabank Deutsche Girozentrale accumulated 459,526 shs or 0.29% of the stock. Endurance Wealth Management invested 0.93% of its capital in CVS Health Corporation (NYSE:CVS). Curbstone Financial Mngmt accumulated 7,250 shs. Tortoise Mgmt Lc has invested 0.01% in CVS Health Corporation (NYSE:CVS). Addison reported 22,301 shs. Benin Management Corp reported 9,780 shs or 0.28% of all its holdings. Moreover, Pensionfund Dsm Netherlands has 0.63% invested in CVS Health Corporation (NYSE:CVS) for 62,000 shs. Jnba has invested 0.1% of its capital in CVS Health Corporation (NYSE:CVS). Bokf Na owns 52,336 shs for 0.1% of their capital. Acadian Asset Mngmt Lc accumulated 0% or 9,779 shs. Sol Capital Company accumulated 8,516 shs or 0.18% of the stock.

CVS Health Corporation registered $713,454 net activity with 2 insider purchases and 1 sale since February 16, 2018. DORMAN DAVID W bought $1.51 million worth of CVS Health Corporation (NYSE:CVS) on Friday, May 4. 10,000 CVS Health Corporation (NYSE:CVS) shs with value of $619,900 were bought by BROWN C DAVID II.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

A total of 13 analysts rate CVS Health (NYSE:CVS) as follows: 11 “Buy”, 2 “Hold” and 0 “Sell”. Тherefore 85% are bullish. (NYSE:CVS) has 25 ratings reports on 16 May 2018 according to StockzIntelligence. On Monday, December 4 the firm has “Buy” rating by RBC Capital Markets given. On Thursday, February 8 the rating was maintained by RBC Capital Markets with “Buy”. On Tuesday, December 26 Tigress Financial maintained CVS Health Corporation (NYSE:CVS) with “Buy” rating. On Friday, January 5 the stock has “Overweight” rating by Morgan Stanley. The company rating was maintained by SunTrust on Thursday, January 4. On Tuesday, February 13 the firm has “Neutral” rating given by Citigroup. On Tuesday, April 10 Leerink Swann maintained CVS Health Corporation (NYSE:CVS) with “Buy” rating. On Wednesday, May 2 Oppenheimer maintained CVS Health Corporation (NYSE:CVS) rating. Oppenheimer has “Buy” rating and $8600 target. The stock rating was maintained by Mizuho with “Buy” on Wednesday, January 24. On Tuesday, April 17 the stock has “Buy” rating by SunTrust.

For more CVS Health Corporation (NYSE:CVS) news posted briefly go to: Streetinsider.com, Seekingalpha.com, Prnewswire.com, Fool.com or 247Wallst.com. The titles are as follows: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” posted on May 15, 2018, “Trade Mistake 3: CVS Boredom Trade” on May 09, 2018, “Increasing Health-conscious and Sports Vision Treatments Impacting HealthCare Sector” with a publish date: May 16, 2018, “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” and the last “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” with publication date: April 29, 2018.

CVS Health Corporation (NYSE:CVS) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: